Trial · NCT00183092
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-blind (Baseline - Month 2) | STARTED | Quinacrine | 23 | |
| Double-blind (Baseline - Month 2) | STARTED | Placebo | 28 | |
| Double-blind (Baseline - Month 2) | STARTED | Study Drug (Quinacrine) During Open-Label Period | 0 | |
| Double-blind (Baseline - Month 2) | STARTED | Study Drug (Placebo) During Open-Label Period | 0 | |
| Double-blind (Baseline - Month 2) | Alive at Month 2 | Quinacrine | 13 | |
| Double-blind (Baseline - Month 2) | Alive at Month 2 | Placebo | 19 | |
| Double-blind (Baseline - Month 2) | Alive at Month 2 | Study Drug (Quinacrine) During Open-Label Period | 0 | |
| Double-blind (Baseline - Month 2) | Alive at Month 2 | Study Drug (Placebo) During Open-Label Period | 0 | |
| Double-blind (Baseline - Month 2) | Came in for Month 2 Visit | Quinacrine | 10 | |
| Double-blind (Baseline - Month 2) | Came in for Month 2 Visit | Placebo | 16 | |
| Double-blind (Baseline - Month 2) | Came in for Month 2 Visit | Study Drug (Quinacrine) During Open-Label Period | 0 | |
| Double-blind (Baseline - Month 2) | Came in for Month 2 Visit | Study Drug (Placebo) During Open-Label Period | 0 | |
| Double-blind (Baseline - Month 2) | COMPLETED | Quinacrine | 11 | |
| Double-blind (Baseline - Month 2) | COMPLETED | Placebo | 16 | |
| Double-blind (Baseline - Month 2) | COMPLETED | Study Drug (Quinacrine) During Open-Label Period | 0 | |
| Double-blind (Baseline - Month 2) | COMPLETED | Study Drug (Placebo) During Open-Label Period | 0 | |
| Double-blind (Baseline - Month 2) | NOT COMPLETED | Quinacrine | 12 | |
| Double-blind (Baseline - Month 2) | NOT COMPLETED | Placebo | 12 | |
| Double-blind (Baseline - Month 2) | NOT COMPLETED | Study Drug (Quinacrine) During Open-Label Period | 0 | |
| Double-blind (Baseline - Month 2) | NOT COMPLETED | Study Drug (Placebo) During Open-Label Period | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00183092/flow